Global Finance & Technology Network to Host the Inaugural Black Swan Summit 2025 to Tackle Global Disruptions and Shape a Resilient Future
PERTH, Australia, March 13, 2025 /PRNewswire/ -- Perth will host the inaugural Black Swan Summit, an ambitious international foresight and R&D forum presented by the Global Finance & Technology Network (GFTN) at the University of Western...
FROM BAKU TO BELÉM: MALAYSIA'S COP29 LEADERSHIP DRIVING REGIONAL AND GLOBAL CLIMATE ACTION
BAKU, Azerbaijan, March 13, 2025 /PRNewswire/ -- As the world grapples with the ever-evolving challenges of climate change, Malaysia remains resolute in its commitment to the Paris Agreement even as key global players have chosen to step back from...
The Society of Actuaries Announces Opening of Singapore Office
SINGAPORE and CHICAGO, March 13, 2025 /PRNewswire/ -- The Society of Actuaries (SOA), the world's largest actuarial professional organization, announces the opening of a new regional office in Singapore. Actuaries are professional experts in...
WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards 2025
SHANGHAI, March 13, 2025 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates...
ANGEL Unveils Innovative Water Purification Technology at Aquatech Amsterdam 2025
AMSTERDAM, March 13, 2025 /PRNewswire/ -- Aquatech Amsterdam 2025, the world's largest water technology exhibition, was held from March 11 to 14 at the RAI Amsterdam Convention Centre. The event gathered global industry leaders, experts, research...
HTX Ventures: DeepSeek Triggers AI's "iPhone Moment", Accelerating AI Agents into Real Crypto Use
SINGAPORE, March 13, 2025 /PRNewswire/ -- HTX Ventures recently released its latest research report, titled "DeepSeek Ignites AI's 'iPhone Moment' as Agent Tokens Integrate into Real-World Crypto." The report explores how DeepSeek's use of pure...
BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors
SHANGHAI, March 13, 2025 /PRNewswire/ -- BioCity Biopharmaceutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced that it has entered into a clinical trial collaboration agreement with MSD (Merck & Co., Inc., Rahway, NJ,...
Jewellery & Gem ASEAN Bangkok (JGAB) 2025: Connecting ASEAN's Gem and Jewellery Business to the Global Market
BANGKOK, March 13, 2025 /PRNewswire/ -- Jewellery & Gem ASEAN Bangkok 2025 (JGAB 2025), scheduled to take place from April 23-26, 2025, at the Queen Sirikit National Convention Center in Bangkok, is set to be the premier B2B platform in...